Latest Share Chat

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Buy GSK Shares
Add GSK to Watchlist
Add GSK to Alert

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1,773.50

Bid: 1,772.00

Ask: 1,772.50

Change: 12.50 (0.71%)

Spread: 0.50 (0.028%)

Open: 1,770.00

High: 1,776.00

Low: 1,766.00

Prev. Close: 1,761.00

Last checked at -

UK BROKER RATINGS SUMMARY: Bank Of America Downgrades Morrisons

Mon, 06th Jan 2020 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

BANK OF AMERICA CUTS WM MORRISON SUPERMARKETS TO 'UNDERPERFORM' ('NEUTRAL')

----------

GOLDMAN SACHS RAISES BP PRICE TARGET TO 750 (730) PENCE - 'CONVICTION BUY LIST'

----------

MORGAN STANLEY RAISES GLAXOSMITHKLINE PRICE TARGET TO 1740 (1640) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES ASTRAZENECA PRICE TARGET TO 8100 (7400) PENCE - 'EQUAL-WEIGHT'

----------

SOCGEN CUTS NEXT TO 'SELL' ('HOLD') - TARGET 6588 (6301) PENCE

----------

BERNSTEIN RAISES DIAGEO PRICE TARGET TO 3400 (3250) PENCE - 'MARKET-PERFORM'

----------

BARCLAYS RAISES ASHTEAD GROUP PRICE TARGET TO 3195 (2430) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES GLAXOSMITHKLINE PRICE TARGET TO 1900 (1700) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES ASTRAZENECA PRICE TARGET TO 8500 (7900) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS HIKMA PHARMACEUTICALS TO 'UNDERWEIGHT' ('NEUTRAL') - TARGET 1850 (1800) PENCE

----------

DEUTSCHE BANK RAISES AVIVA PRICE TARGET TO 470 (450) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES HARGREAVES LANSDOWN PRICE TARGET TO 1800 (1700) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES LEGAL & GENERAL PRICE TARGET TO 335 (290) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES STANDARD LIFE PRICE TARGET TO 320 (265) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS ST JAMES'S PLACE TO 'HOLD' ('BUY') - TARGET 1220 (1190) PENCE

----------

DEUTSCHE BANK RAISES PRUDENTIAL PRICE TARGET TO 1500 (1450) PENCE - 'HOLD'

----------

FTSE 250

----------

UBS RAISES SHAFTESBURY PRICE TARGET TO 915 (860) PENCE - 'NEUTRAL'

----------

UBS RAISES GREAT PORTLAND PRICE TARGET TO 965 (830) PENCE - 'BUY'

----------

UBS RAISES DERWENT LONDON PRICE TARGET TO 4425 (3750) PENCE - 'BUY'

----------

JPMORGAN CUTS ASTON MARTIN LAGONDA PRICE TARGET TO 500 (570) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES SERCO GROUP PRICE TARGET TO 185 (170) PENCE - 'BUY'

----------

JEFFERIES RAISES MARKS & SPENCER PRICE TARGET TO 230 (207) PENCE - 'HOLD'

----------

JEFFERIES RAISES HAYS PRICE TARGET TO 165 (145) PENCE - 'HOLD'

----------

JEFFERIES CUTS PAGEGROUP TO 'HOLD' ('BUY') - TARGET 555 (540) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

BARCLAYS RAISES JOHNSON SERVICE GROUP TARGET TO 220 (210) PENCE - 'OVERWEIGHT'

----------

DEUTSCHE BANK RAISES JUST GROUP PRICE TARGET TO 70 (54) PENCE - 'HOLD'

----------

JEFFERIES CUTS GAMMA COMMUNICATIONS TO 'HOLD' (BUY) - TARGET 1280 (1320) PENCE

----------

BERENBERG RAISES ON THE BEACH GROUP PRICE TARGET TO 540 (480) PENCE - 'BUY'

----------

BERENBERG RAISES HOLLYWOOD BOWL PRICE TARGET TO 310 (280) PENCE - 'BUY'

----------

More News

12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Latest Share Chat

Glaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Bank Of America Downgrades Morrisons

Login to your account

Quickpicks are a member only feature

Login to your account